New Guidelines Recommend Metformin to Combat Weight Gain from Antipsychotics
2024-12-30
Author: Mei
Introduction
In an important development for mental health treatment, a recent guideline released on December 9, 2024, in the Schizophrenia Bulletin highlights the use of metformin as a preventive measure against antipsychotic-induced weight gain (AIWG).
Development of the Guideline
The guideline, spearheaded by Aoife Carolan and her team from Saint John of God Hospital in Dublin, was meticulously crafted using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) framework. This marks a significant stride in addressing a common and concerning side effect of antipsychotic medications, which can lead to substantial weight gain in patients.
Findings on Metformin
According to the guideline, metformin stands out as the only pharmacological option proven to effectively mitigate AIWG. Research indicates that when metformin is co-prescribed alongside antipsychotic medications, it can lead to a reduction in weight gain of approximately 4.03 kg compared to those receiving antipsychotics alone.
Recommendations for Use
The guideline emphasizes specific scenarios for the administration of metformin. Strong recommendations advocate for its use in conjunction with medium-risk antipsychotic medications when patients present one or more cardiometabolic risk factors or are aged between 10 to 25 years. Furthermore, if a patient experiences more than a 3% increase in baseline body weight during the first year of antipsychotic treatment, the initiation of metformin is advised.
Expert Commentary
'This is the first comprehensive evidence-based guideline employing AGREE II and GRADE methodologies for the use of metformin to prevent AIWG,' stated the research team. They further highlighted that the effective implementation and evaluation of these guidelines will rely on a shared decision-making approach and an assessment of both the challenges and supports related to their application.
Conclusion
As mental health awareness continues to grow, these guidelines represent a pivotal resource for healthcare professionals, offering a practical solution to a pressing issue faced by many individuals undergoing antipsychotic treatment.
Call to Action
Stay tuned as more research emerges on effective strategies to manage the side effects of mental health medications!